1-Trichloromethyl-1,2,3,4-tetrahydro-β-carboline-induced apoptosis in the human neuroblastoma cell line SK-N-SH

Journal of Neurochemistry

Volumn 91, Issue 2, 2004, Pages 263-273

  Akundi, Ravi Shankar ^a   Macho, Antonio ^b   Muñoz, Eduardo ^b   Lieb, Klaus ^a   Bringmann, Gerhard ^c   Clement, Hans Willi ^a   Hüll, Michael ^a   Fiebich, Bernd L ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF CÓRDOBA   (Spain)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

1 trichloromethyl 1, 2, 3, 4 tetrahydro carboline 263 273; Chloral hydrate; Neurotoxicity; Parkinson's disease; Trichloroethylene

Indexed keywords

1 TRICHLOROMETHYL 1,2,3,4 TETRAHYDRO BETA CARBOLINE; 1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; 3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; BETA CARBOLINE DERIVATIVE; CASPASE 3; CHLORAL HYDRATE; CYTOCHROME C; DNA FRAGMENT; GLUTAMATE DEHYDROGENASE; MANGANESE; OXIDOPAMINE; PROTEIN BAD; PROTEIN BAX; PROTEIN BCL X; PROTEIN BID; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; ROTENONE; TRICHLOROETHYLENE; TRYPTAMINE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BLOOD BRAIN BARRIER; BRAIN MITOCHONDRION; CELL VIABILITY; CONTROLLED STUDY; ENZYME RELEASE; FLOW CYTOMETRY; GENE ACTIVATION; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; NEUROTOXICITY; NICK END LABELING; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

APOPTOSIS; CARBOLINES; CASPASE 3; CASPASES; CELL LINE, TUMOR; CELL SURVIVAL; CYTOCHROMES C; ENZYME INDUCTION; GENE EXPRESSION; HUMANS; MITOCHONDRIA; NEUROBLASTOMA; NEURONS; PARKINSON DISEASE; PROTEIN KINASE C;

EID: 5444224997     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2004.02710.x     Document Type: Article

References (57)

1. Ahmadi F. A., Linseman D. A., Grammatopoulos T. N., Jones S. M., Bouchard R. J., Freed C. R., Heidenreich K. A. and Zawada W. M. (2003) The pesticide rotenone induces caspase-3-mediated apoptosis in ventral mesencephalic dopaminergic neurons. J. Neurochem. 87, 914-921.
2. Akao Y., Maruyama W., Shimizu S., Yi H., Nakagawa Y., Shamoto-Nagai M., Youdim M. B., Tsujimoto Y. and Naoi M. (2002) Mitochondrial permeability transition mediates apoptosis induced by N-methyl(R)salsolinol, an endogenous neurotoxin, and is inhibited by Bcl-2 and rasagiline, N-propargyl-1 (R)-aminoindan. J. Neurochem. 82, 913-923.
3. Akundi R. S., Hull M., Clement H. W. and Fiebich B. L. (2003) 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo) induces apoptosis in human neuroblastoma cell lines. Ann. NY Acad. Sci. 1010, 304-306.
4. Albores R., Neafsey E. J., Drucker G., Fields J. Z. and Collins M. A. (1990) Mitochondrial respiratory inhibition by N-methylated beta-carboline derivatives structurally resembling N-methyl-4-phenylpyridine. Proc. Natl Acad. Sci. USA 87, 9368-9372.
5. American Academy of Pediatrics Committee on Drugs and Committee on Environmental Health (1993) Use of chloral hydrate for sedation in children. Pediatrics 92, 471-473.
6. Anantharam V, Kitazawa M., Wagner J., Kaul S. and Kanthasamy A. G. (2002) Caspase-3-dependent proteolytic cleavage of protein kinase Cdelta is essential for oxidative stress-mediated dopaminergic cell death after exposure to methylcyclopentadienyl manganese tricarbonyl. J. Neurosci. 22, 1738-1751.
7. Betarbet R., Sherer T. B., MacKenzie G., Garcia-Osuna M., Panov A. V. and Greenamyre J. T. (2000) Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3, 1301-1306.
8. Bringmann G. and Hille A. (1990) Endogenous alkaloids in man, VII: 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline - a potential chloral-derived indol alkaloid in man. Arch. Pharm. (Weinheim) 323, 567-569.
9. Bringmann G., Munchbach M., Feineis D., Messer K., Diem S., Herderich M., Clement H. W., Stichel-Gunkel C. and Kuhn W. (2002) Endogenous alkaloids in man. XXXVIII. 'Chiral' and 'achiral' determination of the neurotoxin TaClo (1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline) from blood and urine samples by high-performance liquid chromatography - electrospray ionization tandem mass spectrometry. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 767, 321-332.
10. Bruning T. and Bolt H. M. (2000) Renal toxicity and carcinogenicity of trichloroethylene: key results, mechanisms, and controversies. Crit. Rev. Toxicol. 30, 253-285.
11. Chomczynski P. and Sacchi N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
12. Cole W. J., Mitchell R. G. and Salamonsen R. F. (1975) Isolation, characterization and quantitation of chloral hydrate as a transient metabolite of trichloroethylene in man using electron capture gas chromatography and mass fragmentography. J. Pharm. Pharmacol. 27, 167-171.
13. D'Agostino J. and Terndrup T. E. (2000) Chloral hydrate versus midazolam for sedation of children for neuroimaging: a randomized clinical trial. Pediatr. Emerg. Care 16, 1-4.
14. Dawson T. M. and Dawson V. L. (2003) Molecular pathways of neurodegeneration in Parkinson's disease. Science 302, 819-822.
15. Degli E. M. (1998) Inhibitors of NADH-ubiquinone reductase: an overview. Biochim. Biophys. Acta 1364, 222-235.
16. Desagher S., Osen-Sand A., Nichols A., Eskes R., Montessuit S., Lauper S., Maundrell K., Antonsson B. and Martinou J. C. (1999) Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis. J. Cell Biol. 144, 891-901.
17. Eliseev R. A., Salter J. D., Gunter K. K. and Gunter T. E. (2003) Bcl-2 and tBid proteins counter-regulate mitochondrial potassium transport. Biochim. Biophys. Acta 1604, 1-5.
18. Gorell J. M., Rybicki B. A., Cole J. C. and Peterson E. L. (1999) Occupational metal exposures and the risk of Parkinson's disease. Neuroepidemiology 18, 303-308.
19. Green D. R. and Reed J. C. (1998) Mitochondria and apoptosis. Science 281, 1309-1312.
20. Greenberg S. B., Faerber E. N., Aspinall C. L. and Adams R. C. (1993) High-dose chloral hydrate sedation for children undergoing MR imaging: safety and efficacy in relation to age. AJR Am. J. Roentgenol. 161, 639-641.
21. Gschwendt M., Dieterich S., Rennecke J., Kittstein W., Mueller H. J. and Johannes F. J. (1996) Inhibition of protein kinase C mu by various inhibitors. Differentiation from protein kinase c isoenzymes. FEBS Lett. 392, 77-80.
22. Guehl D., Bezard E., Dovero S., Boraud T., Bioulac B. and Gross C. (1999) Trichloroethylene and parkinsonism: a human and experimental observation. Eur. J. Neurol. 6, 609-611.
23. Han Z., Hendrickson E. A., Bremner T. A. and Wyche J. H. (1997) A sequential two-step mechanism for the production of the mature p17:p12 form of caspase-3 in vitro. J. Biol. Chem. 272, 13 432-13 436.
24. Hartmann A., Hunot S., Michel P. P. et al. (2000) Caspase-3: a vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease. Proc. Natl Acad. Sci. USA 97, 2875-2880.
25. Herraiz T. and Galisteo J. (2003) Tetrahydro-beta-carboline alkaloids occur in fruits and fruit juices. Activity as antioxidants and radical scavengers. J. Agric. Food Chem. 51, 7156-7161.
26. Hoglinger G. U., Feger J., Prigent A., Michel P. P., Parain K., Champy P., Ruberg M., Oertel W. H. and Hirsch E. C. (2003) Chronic systemic complex 1 inhibition induces a hypokinetic multisystem degeneration in rats. J. Neurochem. 84, 491-502.
27. Holmuhamedov E. L., Jovanovic S., Dzeja P. P., Jovanovic A. and Terzic A. (1998) Mitochondrial ATP-sensitive K+ channels modulate cardiac mitochondrial function. Am. J. Physiol. 275, H1567-H1576.
28. Inoue I., Nagase H., Kishi K. and Higuti T. (1991) ATP-sensitive K+ channel in the mitochondrial inner membrane. Nature 352, 244-247.
29. Janetzky B., God R., Bringmann G. and Reichmann H. (1995) 1-Trichloromethyl-1,2,3,4-tetrahydro-beta-carboline, a new inhibitor of complex 1. J. Neural Transm. Suppl. 46, 265-273.
30. Jenner P. (2001) Parkinson's disease, pesticides and mitochondrial dysfunction. Trends Neurosci. 24, 245-247.
31. Kaul S., Kanthasamy A., Kitazawa M., Anantharam V. and Kanthasamy A. G. (2003) Caspase-3 dependent proteolytic activation of protein kinase Cdelta mediates and regulates 1-methyl-4-phenylpyridinium (MPP+)-induced apoptotic cell death in dopaminergic cells: relevance to oxidative stress in dopaminergic degeneration. Eur. J. Neurosci. 18, 1387-1401.
32. Kroemer G., Dallaporta B. and Resche-Rigon M. (1998) The mitochondrial death/life regulator in apoptosis and necrosis. Annu. Rev. Physiol. 60, 619-642.
33. Langston J. W., Ballard P., Tetrad J. W. and Irwin I. (1983) Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219, 979-980.
34. Li N., Ragheb K., Lawler G., Sturgis J., Rajwa B., Melendez J. A. and Robinson J. P. (2003) Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production. J. Biol. Chem. 278, 8516-8525.
35. Liu Y., Fallon L., Lashuel H. A., Liu Z. and Lansbury P. T. Jr (2002a) The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility. Cell 111, 209-218.
36. Liu Y., Fiskum G. and Schubert D. (2002b) Generation of reactive oxygen species by the mitochondrial electron transport chain. J. Neurochem. 80, 780-787.
37. Lotharius J. and O'Malley K. L. (2000) The parkinsonism-inducing drug 1-methyl-4-phenylpyridinium triggers intracellular dopamine oxidation. A novel mechanism of toxicity. J. Biol. Chem. 275, 38 581-38 588.
38. Manning-Bog A. B., McCormack A. L., Li J., Uversky V. N., Fink A. L. and Di Monte D. A. (2002) The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein. J. Biol. Chem. 277, 1641-1644.
39. Mattson M. P. and Liu D. (2003) Mitochondrial potassium channels and uncoupling proteins in synaptic plasticity and neuronal cell death. Biochem. Biophys. Res. Commun. 304, 539-549.
40. McNaught K. S., Carrupt P. A., Altomare C., Cellamare S., Carotti A., Testa B., Jenner P. and Marsden C. D. (1998) Isoquinoline derivatives as endogenous neurotoxins in the aetiology of Parkinson's disease. Biochem. Pharmacol. 56, 921-933.
41. Melchior C. and Collins M. A. (1982) The route and significance of endogenous synthesis of alkaloids in animals. Crit. Rev. Toxicol. 9, 313-356.
42. Morikawa N., Naoi M., Maruyama W., Ohta S., Kotake Y., Kawai H., Niwa T., Dostert P. and Mizuno Y. (1998) Effects of various tetrahydroisoquinoline derivatives on mitochondrial respiration and the electron transfer complexes. J. Neural Transm. 105, 677-688.
43. Napoli K. L., Ingall C. G. and Martin G. R. (1996) Safety and efficacy of chloral hydrate sedation in children undergoing echocardiography. J. Pediatr. 129, 287-291.
44. Polymeropoulos M. H., Lavedan C., Leroy E. et al. (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276, 2045-2047.
45. Reif J. S., Burch J. B., Nuckols J. R., Metzger L., Ellington D. and Anger W. K. (2003) Neurobehavioral effects of exposure to trichloroethylene through a municipal water supply. Environ. Res. 93, 248-258.
46. Riederer P., Foley P., Bringmann G., Feineis D., Bruckner R. and Gerlach M. (2002) Biochemical and pharmacological characterization of 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline: a biologically relevant neurotoxin? Eur. J. Pharmacol. 442, 1-16.
47. Ronchera-Oms C. L., Casillas C., Marti-Bonmati L., Poyatos C., Tomas J., Sobejano A. and Jimenez N. V. (1994) Oral chloral hydrate provides effective and safe sedation in paediatric magnetic resonance imaging. J. Clin. Pharm. Ther. 19, 239-243.
48. Sato T., O'Rourke B. and Marban E. (1998) Modulation of mitochondrial ATP-dependent K+ channels by protein kinase C. Circ. Res. 83, 110-114.
49. Schapira A. H., Cooper J. M., Dexter D., Jenner P., Clark J. B. and Marsden C. D. (1989) Mitochondrial complex I deficiency in Parkinson's disease. Lancet 1, 1269.
50. Schiestl R. H., Aubrecht J., Khogali F. and Carls N. (1997) Carcinogens induce reversion of the mouse pink-eyed unstable mutation. Proc. Natl Acad. Sci. USA 94, 4576-4581.
51. Sherer T. B., Betarbet R., Testa C. M., Seo B. B., Richardson J. R., Kim J. H., Miller G. W., Yagi T., Matsuno-Yagi A. and Greenamyre J. T. (2003) Mechanism of toxicity in rotenone models of Parkinson's disease. J. Neurosci. 23, 10 756-10 764.
52. Swerdlow R. H., Parks J. K., Davis J. N. et al. (1998) Matrilineal inheritance of complex I dysfunction in a multigenerational Parkinson's disease family. Ann. Neurol. 44, 873-881.
53. Tai K. K., McCrossan Z. A. and Abbott G. W. (2003) Activation of mitochondrial ATP-sensitive potassium channels increases cell viability against rotenone-induced cell death. J. Neurochem. 84, 1193-1200.
54. Tatton W. G., Chalmers-Redman R., Brown D. and Tatton N. (2003) Apoptosis in Parkinson's disease: signals for neuronal degradation. Ann. Neurol. 53, S61-S70.
55. Viswanath V, Wu Y., Boonplueang R., Chen S., Stevenson F. F., Yantiri F., Yang L., Beal M. F. and Andersen J. K. (2001) Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced Parkinson's disease. J. Neurosci. 21, 9519-9528.
56. Warner T. T. and Schapira A. H. (2003) Genetic and environmental factors in the cause of Parkinson's disease. Ann. Neurol. 53, S16-S23.
57. Wu C. and Schaum J. (2000) Exposure assessment of trichloroethylene. Environ. Health Perspect. 108, 359-363.